Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.
about
Cancer genome landscapesNCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomesMolecular biology of lung cancerTyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical ImplicationsYin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implicationIs the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC?Paradoxical role of SOX2 in gastric cancerCancer Stem Cell Hierarchy in Glioblastoma MultiformeNotch Signaling in Neuroendocrine TumorsEpigenetic modulators, modifiers and mediators in cancer aetiology and progressionTargeted drugs in small-cell lung cancerSmall cell lung cancer (SCLC): no treatment advances in recent yearsCancer stem cells in small cell lung cancerCellular and molecular biology of small cell lung cancer: an overviewNovel therapies in small cell lung cancerMutant p53: Multiple Mechanisms Define Biologic Activity in CancerDifferences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese populationOrigins, genetic landscape, and emerging therapies of small cell lung cancerMediator kinase module and human tumorigenesisThe role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lungPredictive biomarkers in precision medicine and drug development against lung cancerTransformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of originGenomic profiling of small-cell lung cancer: the era of targeted therapiesMutational signatures: the patterns of somatic mutations hidden in cancer genomesFunctional genomics lead to new therapies in follicular lymphomaFrom fly wings to targeted cancer therapies: a centennial for notch signalingEmerging patterns of somatic mutations in cancerBidirectional interconversion of stem and non-stem cancer cell populations: A reassessment of theoretical models for tumor heterogeneityNew and emerging developments in extensive-stage small cell lung cancer therapeuticsHistopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumorsBiology of MET: a double life between normal tissue repair and tumor progressionComprehensive molecular profiling of lung adenocarcinoma.Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents.Inactivating CUX1 mutations promote tumorigenesisFormation of Tumorspheres with Increased Stemness without External Mitogens in a Lung Cancer ModelIdentification of Circulating Tumor DNA for the Early Detection of Small-cell Lung CancerPharmacogenomic approach to identify drug sensitivity in small-cell lung cancerSignatures of mutational processes in human cancerNfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility.Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer
P2860
Q22242276-A475D179-CE6E-43AA-B9E1-98F9DE651995Q24596715-A58BF9BE-B1D1-4365-9CFC-C2ECDEF33A1DQ24606677-589DC520-298A-4F2A-9192-0F51F755F001Q26741318-7C219C6C-E6DD-4CB7-B277-C18FD47F7E50Q26745972-316C3F58-690F-46F0-B03A-48A3490F7497Q26748741-F56263D1-24E2-4205-BCAC-27DC87485D99Q26749130-30865069-4F06-4363-B967-5CA630D2F5DBQ26752312-44C11297-1389-43F1-93C2-CE80408A8FFDQ26752380-9C7EEF3C-BD1C-46A4-8DA8-F32DD2AFAA60Q26766149-6F9FF16C-FD7A-4236-A73E-888C98D01026Q26767017-E484083A-691D-4EB8-90B3-6499DBDE91D5Q26767020-829F98C6-D0EE-4517-9F6D-C36E8EE49600Q26767026-5D60FD35-C818-4B70-A5D3-D340F0E3F181Q26767029-7C6B3FDD-9437-4647-8336-0A7CC47D2369Q26775390-5FF0795F-EE34-42F6-B6BA-FD01E6145145Q26776020-23CF44BA-7532-4636-B1DC-B48B2B5D1FBFQ26786594-F66462FD-0EBB-4673-BDD2-C6423F192E5EQ26798218-F8FC3EEC-C6C8-4207-A4D1-02E303AD09CFQ26800203-BE77E9A3-709D-4389-9A85-2A2138B34D2DQ26822879-95FBB814-88EC-43DD-8942-FFBDD99E4C58Q26824536-05A33845-89A1-498B-AAD1-8AFF6B12FD70Q26826437-7BB2ED3D-A52F-42A9-BF4A-B970D1A00E27Q26826915-EFAFEA8D-3ABA-4EBD-BC1D-5CCDE5BDF42DQ26850125-23C573D6-5469-42F5-8241-32FA9F383703Q26852415-12D11B6F-EFCF-4146-AF53-100CDCA95496Q27004534-341E52DB-0A51-451C-91A3-97DA2DA1F109Q27014126-EF1F946F-C29F-411C-9EA9-2A75A23E081AQ28066409-DCC4324F-D605-4021-9041-FC7D3BFA9714Q28076304-BB3EFAB5-1C54-4ED1-9268-754FF8E594E2Q28077504-692DB9C7-195D-4979-A061-5C4579D9F6CBQ28085247-A1D49F35-5BC7-47D3-8366-7046B38F0BD0Q28244995-B7C92CFC-E960-49D4-B043-215C452B1619Q28261026-23D3C63F-8EFC-4F32-803B-1DB45AE80031Q28303563-ADDF9C52-E2D0-4134-B40B-1A450143949EQ28385645-8BCBDE1D-B0A7-438C-866B-9708105FF1ABQ28390093-3227C4B1-B515-415A-B7CA-3752E74DDD67Q28542859-B388B5AE-51C9-4DD6-8D3D-AFBD75302564Q29547191-2B6BB64D-4806-43AB-B352-3D404291564EQ30276428-4A3DFE8E-9598-43E4-B25C-B7ED3C66A59BQ30276619-D9C7FCA7-378C-4A89-A81B-63034D82D765
P2860
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Comprehensive genomic analysis ...... ene in small-cell lung cancer.
@ast
Comprehensive genomic analysis ...... ene in small-cell lung cancer.
@en
type
label
Comprehensive genomic analysis ...... ene in small-cell lung cancer.
@ast
Comprehensive genomic analysis ...... ene in small-cell lung cancer.
@en
prefLabel
Comprehensive genomic analysis ...... ene in small-cell lung cancer.
@ast
Comprehensive genomic analysis ...... ene in small-cell lung cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Comprehensive genomic analysis ...... ene in small-cell lung cancer.
@en
P2093
Adi F Gazdar
Bijay S Jaiswal
Catherine K Foo
Celina Sanchez Rivers
Chaitali Parikh
David S Shames
Deepali Bhatt
Diego D Paskulin
Emily A Bergbower
Eric W Stawiski
P2860
P2888
P304
P356
10.1038/NG.2405
P407
P577
2012-09-02T00:00:00Z
P5875
P6179
1043035086